Abstract
Radiation therapy is an important modality used in the treatment of many head and neck malignancies as part of the local tumor management. Radiotherapy is used in cases of unresectable or high-grade tumors. Improvements in technology such as the use of intensity-modulated radiation therapy or proton beam will help to minimize the late effects of treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Powell S, McMillan TJ. DNA damage and repair following treatment with ionizing radiation. Radiother Oncol. 1990;19(2):95–108.
Prise KM, Schettino G, Folkard M, et al. New insights on cell death from radiation exposure. Lancet Oncol. 2005;6(7):520–8.
Painter RB, Young BR. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci U S A. 1980;77(12):7315–7.
Taylor AM, Harnden DG, Arlett CF, et al. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 1975;258(5534):427–9.
Demuth I, Digweed M. The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome. Oncogene. 2007;26(56):7792–8.
Rubin P, Casarette GW. Clinical radiation pathology. Philadelphia:Saunders; 1968.
Miller AR, Martenson JA, Nelson H, et al. The incidence and clinical consequences of treatment-related bowel injury. Int J Radiat Oncol Biol Phys. 1999;43(4):817–25.
Yock T, Schneider R, Friedmann A, Adams J, Fullerton B, Tarbell N. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys. 2005;63(4):1161–8.
Wolden SL, Anderson JR, Crist WM, et al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol. 1999;17(11):3468–75.
Wolden SL, Chen WC, Pfister DG, et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64(1):57–62.
Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys. 1995;31(5):1165–70.
Ullrich NJ, Robertson R, Kinnamon DD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007;68(12):932–8.
Lew SM, Morgan JN, Psaty E, et al. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg. 2006;104(2 Suppl):103–7.
Mulhern RK, Merchant TE, Gajjar A, et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5(7):399–408.
Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2356–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Marcus, K. (2014). Radiotherapy. In: Rahbar, R., Rodriguez-Galindo, C., Meara, J., Smith, E., Perez-Atayde, A. (eds) Pediatric Head and Neck Tumors. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8755-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8755-5_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8754-8
Online ISBN: 978-1-4614-8755-5
eBook Packages: MedicineMedicine (R0)